Neeraj Agarwal MD @neerajaiims Of Huntsman Cancer Institute Discusses TALAPRO-2 Trial Patient Screening: No Need To Be Screened For Specific Mutations, Not Ruling Out Any Patients.
TALAPRO-2 Trial Patient Screening: No Need To Be Screened For Specific Mutations, Not Ruling Out Any Patients
